PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
01-May-2024 SYGNATURE DISCOVERY RECEIVES ECOVADIS AWARD FOR SUSTAINABLE EXCELLENCE SYGNATURE DISCOVERY
01-May-2024 Ardena's Nanomedicines Facility Marks €20 Million Expansion with first GMP approval Ardena
30-Apr-2024 Beckman Coulter Life Sciences and Watchmaker Genomics Announce Partnership Beckman Coulter Life Sciences
30-Apr-2024 Bioscript Group acquires Enzyme Communications to bolster its medical writing, scientific content creation and storytelling capabilities Bioscript Group
30-Apr-2024 Transformative partnership between the Medicines Patent Pool and ViiV Healthcare enables 24 million people in low- and middle-income countries to access innovative HIV treatment ViiV Healthcare
30-Apr-2024 Integrated cancer biotech Infinitopes secures £12.8m seed financing to enhance its Precision ImmunomicsTM antigen discovery technologies to target five more cancers Infinitopes Precision Immunomics
30-Apr-2024 Locate Bio Raises £9.2 Million to Progress LDGraft Clinical Study for Anterior Lumbar Interbody Fusion Locate Bio
29-Apr-2024 CanSinoBIO CSO Shares the Latest Results of the Company's Globally Innovative Pneumococcal Vaccine CanSino Biologics Inc
29-Apr-2024 selectION Announces Positive Results from Phase 1b Clinical Trial Evaluating si-544 in Patients with Atopic Dermatitis selectION, Inc.
26-Apr-2024 Swedencare launches NaturVet by Swedencare: Bringing America’s leading pet brand to Europe Swedencare
26-Apr-2024 OncoZenge Releases Paper on BupiZenge™ Addressing Unmet Medical Needs OncoZenge
26-Apr-2024 Liebherr presents its innovative cooling solutions at Clinical Pharmacy Congress 2024 Liebherr
26-Apr-2024 eyeDNA Therapeutics to Present 2-year Follow-up Phase I/II Data on its Investigational Gene Therapy HORA-PDE6b for Retinitis Pigmentosa at the ARVO 2024 Annual Meeting eyeDNA Therapeutics
25-Apr-2024 PureTech Announces Annual Results for Year Ended December 31, 2023 PureTech
25-Apr-2024 BIAL appoints Pierluigi Antonelli as Non-Executive Board Member BIAL
25-Apr-2024 AAVantgarde announces updated NHP data from its Stargardt disease program in a poster presentation at the ARVO 2024 annual meeting AAVantgarde Bio
25-Apr-2024 Cambridge Cognition spin-out Monument Therapeutics accesses £1.5m for schizophrenia clinical development Cambridge Cognition
25-Apr-2024 New £40M research centres will unlock new tests, treatments and cures for people living with rare diseases LifeArc
25-Apr-2024 LifeArc launches £40M research centres that will unlock new tests, treatments and cures for people living with rare diseases LifeArc
23-Apr-2024 AAVantgarde presents positive preclinical data in large animal models from its Stargardt disease program in an oral presentation at the ASGCT 2024 annual meeting AAVantgarde Bio